Sentence examples for multiple myeloma using from inspiring English sources

Immunotherapies have achieved remarkable success in treating different forms of cancer including melanoma, non-small cell lung carcinoma, bladder cancer, synovial cell sarcoma, and multiple myeloma using immune checkpoint blockade or gene-engineered T-cells.

Lionetti et al. identified the miRNA expression patterns and miRNA-mRNA regulatory network in distinct molecular groups of multiple myeloma using miRNA-mRNA dual expression profile data [ 14].

Table 1 summarizes cohort and case control studies of bladder cancer, non-Hodgkin lymphoma, and multiple myeloma using a higher quality exposure assessment methodology; summaries of the other cancer sites can be found in the Toxicological Review (U.S. EPA 2012b).

We examined the hypothesis that POEMS syndrome is a paraneoplastic disorder associated with plasma cell dyscrasia, and that a therapeutic approach for multiple myeloma using thalidomide and dexamethasone can also be effective for treating POEMS.

For this aspect, we present, in this study, the establishment of two human multiple myeloma cell lines, called SNU_MM1393_BM and SNU_MM1393_SC from a patient with aggressive multiple myeloma using an animal model.

The extension of a large cohort study of sawmill workers, with follow-up to 1995, provided information about risks of relatively rare cancers (e.g., non-Hodgkin lymphoma, multiple myeloma), using a validated exposure assessment procedure that distinguishes between exposures to pentachlorophenol and tetrachlorophenol.

There have been no safety issues with any of the drugs, Dr. Vlasuk said, with the possible exception of a multiple myeloma trial, using very high doses of resveratrol, in which several patients developed a symptom common with the disease.

Nuclear proteins were extracted and isolated from multiple myeloma cells using the Thermo Scientific NE-PER® NE-PER® NuclearoplandiCytoplasmicn Kit protocol.

Plasma cells were isolated from bone marrow taken from Multiple Myeloma patients using standard Ficoll-Hypaque [ 10].

This study investigated the biological significance of the inhibition of fatty acid synthase (FAS) in multiple myeloma (MM) using the small molecule inhibitor Cerulenin.

After these findings were reported, the development of bortezomib for the treatment of multiple myeloma continued using the standard twice-weekly schedule with the 1.3 mg/m dose (12– 12).